| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.500 | None | 0.955 | 1 | 2 | 1980 | 2020 | ||||||||
|
anoctamin 6 | 0.736 | 0.423 | 7.3E-32 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2011 | 2013 | ||||||||
|
MEFV innate immuity regulator, pyrin | 0.440 | 0.885 | 1.0E-14 |
|
disease | 0.200 | None | 1.000 | 1 | 1 | 2008 | 2019 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.200 | None | 0.933 | 1 | 1 | 2001 | 2020 | ||||||||
|
toll like receptor 4 | 0.321 | 0.962 | 4.6E-09 |
|
disease | 0.200 | None | 0.786 | 1 | 1 | 2005 | 2019 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.190 | None | 1.000 | 1 | 1 | 2010 | 2018 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.160 | None | 1.000 | 1 | 1 | 1985 | 2015 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.160 | None | 0.714 | 1 | 3 | 2002 | 2018 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.150 | None | 1.000 | 1 | 1 | 2014 | 2017 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
disease | 0.140 | None | 1.000 | 1 | 1 | 2005 | 2018 | ||||||||
|
interleukin 18 receptor 1 | 0.473 | 0.808 | 8.6E-06 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2010 | 2017 | ||||||||
|
CD6 molecule | 0.489 | 0.808 | 9.3E-05 |
|
disease | 0.130 | None | 1.000 | 1 | 1 | 2016 | 2018 | ||||||||
|
TNF superfamily member 15 | 0.531 | 0.692 | 2.8E-03 |
|
disease | 0.130 | None | 0.750 | 1 | 2 | 2013 | 2015 | ||||||||
|
TNF alpha induced protein 3 | 0.481 | 0.808 | 1.00 |
|
disease | 0.130 | None | 0.750 | 1 | 1 | 2011 | 2019 | ||||||||
|
kinesin family member 21B | 0.805 | 0.192 | 1.8E-06 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2011 | 2015 | ||||||||
|
autophagy related 5 | 0.462 | 0.885 | 0.98 |
|
disease | 0.120 | None | 1.000 | 1 | 1 | 2014 | 2018 | ||||||||
|
TNFAIP3 interacting protein 1 | 0.564 | 0.769 | 0.48 |
|
disease | 0.120 | None | 0.667 | 1 | 1 | 2011 | 2019 | ||||||||
|
tyrosine kinase 2 | 0.505 | 0.769 | 4.5E-08 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2016 | 2018 | ||||||||
|
CDK5 regulatory subunit associated protein 1 like 1 | 0.617 | 0.615 | 1.6E-02 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2016 | 2017 | ||||||||
|
ETS proto-oncogene 1, transcription factor | 0.444 | 0.731 | 0.78 |
|
disease | 0.110 | None | 1.000 | 1 | 2 | 2014 | 2016 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2015 | 2016 | ||||||||
|
aminopeptidase puromycin sensitive | 0.519 | 0.808 | 1.00 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2016 | 2019 | ||||||||
|
interleukin 1 receptor type 1 | 0.509 | 0.769 | 0.15 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2011 | 2016 | ||||||||
|
nuclear factor of activated T cells 1 | 0.517 | 0.731 | 0.16 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2016 | 2017 | ||||||||
|
lymphotoxin beta receptor | 0.592 | 0.692 | 0.31 |
|
disease | 0.110 | None | 1.000 | 1 | 1 | 2011 | 2013 |